SEC Filing Analysis: Celularity Inc (CELU)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Peter Diamandis received a routine, immediately vested grant of 20,385 Restricted Stock Units (RSUs) as compensation.
• Market Impact: Neutral. This is a standard compensation event with a reported value of $0 and is not indicative of a market-moving event.

Company Information

Field	Value
Company	Celularity Inc
Ticker Symbol	CELU
CIK	0001752828
Industry	PHARMACEUTICAL PREPARATIONS [2834]

Insider Information

Field	Value
Name	Diamandis Peter
CIK	0001528288
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4/A
Transaction Date	2026-01-12
Transaction Code	A (Grant, award, or other acquisition)
Security Type	Class A Common Stock
Shares Involved	20,385
Price Per Share	$0.00
Total Value	$0
Shares Owned After	394,150
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	20,385
% of Shares Outstanding	Not Available
Post-Transaction Ownership	394,150 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a reported value of $0 and is immaterial relative to Celularity's $40 million market capitalization.
• Ownership Concentration: The insider's total holdings of 394,150 shares are noted, but their percentage of ownership cannot be calculated as shares outstanding data is not available.
• Dilution Impact: As this is an equity grant, it has a minor dilutive effect on existing shareholders. The exact percentage of dilution cannot be determined without the total number of shares outstanding.
• Transaction Significance: The significance is low. This is a standard equity compensation grant for a director, not an open-market transaction reflecting new investment decisions.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a routine, non-cash compensation event for a director and does not represent an open-market transaction. It is not expected to influence trading behavior.

Volume & Sentiment

• Expected Volume Impact: Negligible. Compensation-related filings typically do not drive trading volume.
• Sentiment Indicator: Neutral. The filing is informational regarding director compensation and does not signal a bullish or bearish stance from the insider.

Additional Context

Transaction Notes

• This Form 4/A is an amendment to a previously filed report.
• The transaction represents a grant of Restricted Stock Units (RSUs) under the company's 2021 Equity Incentive Plan. Per the filing's footnotes, these RSUs vested immediately upon being granted.